Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination

por Hettiarachchi, Ravin, Naidu, Kartik, Payne, Suzanne, Holland, Juliette
Publicado 2022

PB1934: MEASURED OPTIMUM ANTI-SPIKE LEVEL VACCINATION STRATEGY AND ANTI-VIRAL ACCESS RESULT IN LOW COVID HOSPITALISATION AND MORTALITY IN CLL AND MBL

por Shen, Yandong, Freeman, Jane, Kerridge, Ian, Naidu, Kartik, Holland, Juliette, Mulligan, Stephen
Publicado 2023

Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion

por Shen, Yandong, Freeman, Jane A., Holland, Juliette, Naidu, Kartik, Solterbeck, Ann, Van Bilsen, Nenna, Downe, Paul, Kerridge, Ian, Wallman, Lucinda, Akerman, Anouschka, Aggarwal, Anupriya, Milogiannakis, Vanessa, Martins Costa Gomes, Gabriela, Doyle, Chloe M., Sandgren, Kerrie J., Turville, Stuart, Cunningham, Anthony L., Mulligan, Stephen P.
Publicado 2022